Aker BioMarine’s Science Board Meets to Talk Krill

At its first meeting at the beginning of October, Aker BioMarine’s (Oslo, Norway) new science board met to discuss the future of krill phospholipid omega-3s.

Among items discussed, the Aker BioMarine Science Board (ABS) talked about existing data supporting krill oil and omega-3 phospholipids, as well as ongoing clinical trials with Aker BioMarine’s Superba krill oil and global increases in omega-3 consumption and supplementation.

Aker says that its board will provide the company with strategic guidance on ongoing research and product development, including in vitro, preclinical, and clinical studies.